Showing 33 articles by Zekerie Redzheb

Filters Content type: News, About HIV Author: Zekerie Redzheb

Zekerie holds a master’s degree in Virology and tutors both general and molecular biology. He has a vested interest in pandemic viruses and pathogen-host interactions. He is particularly interested in HIV cure research and HIV treatment, as well as environmental and sociocultural influences on the wellbeing of people living with HIV.

LinkedIn

Viral load

Experts publish recommendations on managing low-level but detectable HIV

News
10 July 2026
Cancer

Lymphoma and HIV

About HIV
June 2026
Cancer

Worse HIV control at diagnosis doesn't mean worse lymphoma outcomes

News
8 June 2026
Sexually transmitted infections prevention

DoxyPEP halves overall syphilis cases, with possible indirect benefits for women

News
22 April 2026
Ageing & HIV

People with undetectable HIV age cognitively at the same rate as those without HIV

News
6 February 2026
Antibody-based treatment

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study

News
10 November 2025
The search for a cure

Turning HIV’s power against itself may help target hidden virus – another step towards a cure

News
6 October 2025
Viral load

Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm

News
29 September 2025
Telling people you have HIV

Despite U=U, concerns about sharing HIV status persist among older people

News
22 September 2025
Sexually transmitted infections prevention

Two doses of HPV vaccine as effective as the recommended three-dose schedule for women with HIV

News
13 June 2025
Neurological & cognitive problems

A class of HIV drugs might protect against Alzheimer’s

News
6 May 2024
Changing treatment

Changing HIV treatment

About HIV
April 2024
Viral load

What are logs in viral load results?

About HIV
March 2024
HIV treatment

HIV lifecycle

About HIV
March 2024
The search for a cure

Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir

News
5 March 2024
HIV treatment

Dolutegravir-based triple therapy effectively suppresses HIV-2 viral load in small study

News
30 January 2024
Resistance

Dolutegravir resistance is rare, but some risk factors can up the odds

News
6 December 2023
The search for a cure

Gene editing may not be the safest HIV cure strategy, early findings warn

News
24 November 2023
The search for a cure

Nearly 13% of participants in an African cohort maintain HIV control off treatment

News
9 November 2023
Changing treatment

Increasing and changing pattern of treatment switches among people with HIV

News
23 October 2023
Cardiovascular disease

Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn

News
23 October 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023
Neurological & cognitive problems

HIV in the brain – does it correlate with neurocognitive symptoms?

News
18 October 2023
The search for a cure

Man controls HIV for 23 years after a short course of treatment

News
16 October 2023